Search Within

Helena Alexandra Yu

Formats
  1. Meeting Abstract (160)
  2. Journal Article (105)
  3. Editorial (9)
  4. Review (7)
  5. Book Section (2)
  6. Conference Paper (1)
  7. Correspondence (1)
Groups
  1. Department of Medicine (285)
  2. Solid Tumor Oncology Division (285)
  3. Thoracic Oncology (285)
  4. GSK Faculty (119)
  5. Department of Pathology and Laboratory Medicine (102)
  6. Human Oncology and Pathogenesis Program (100)

More Groups

People
  1. Gregory Riely (107)
  2. Mark Kris (94)
  3. Marc Ladanyi (71)
  4. Charles Rudin (57)
  5. Maria Arcila (55)
  6. Alexander Drilon (36)

More People

Years
  1. 2025 (14)
  2. 2024 (28)
  3. 2023 (30)
  4. 2022 (33)
  5. 2021 (30)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (73)
  2. Journal of Thoracic Oncology (62)
  3. Annals of Oncology (26)
  4. Clinical Cancer Research (18)
  5. International Journal of Radiation Oncology, Biology, Physics (14)
  6. Cancer Discovery (9)

More Publications

Publishers
  1. Elsevier Inc. (84)
  2. American Society of Clinical Oncology (82)
  3. American Association for Cancer Research (31)
  4. Oxford University Press (30)
  5. Nature Publishing Group (11)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (285)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rapid, highly sensitive assay for EGFR T790M mutation detection using droplet digital PCR technology on NGS libraries
    Meeting Abstract

    Borsu, L.; Intrieri, J.; Momin, Z.; Yu, H.; Riely, G.; Ladanyi, M.; Arcila, M.
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Dose optimization of rociletinib for EGFR mutated NSCLC: Benefit/risk analysis from the TIGER-X trial
    Meeting Abstract

    Soria, J. C.; Goldman, J. W.; Wakelee, H.; Gadgeel, S.; Camidge, D. R.; Solomon, B.; Yu, H.; Oxnard, G. R.; Ou, S. H.; Papadimitrakopoulou, V.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M
    Meeting Abstract

    Solomon, B.; Wakelee, H.; Sequist, L. V.; Gadgeel, S.; Soria, J. C.; Goldman, J. W.; Yu, H.; Camidge, D. R.; Papadimitrakopoulou, V.; Matheny, S.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test
    Meeting Abstract

    Gadgeel, S.; Soria, J. C.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Yu, H.; Varga, A.; Solomon, B.; Oxnard, G. R.; Ou, S. H.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement
    Meeting Abstract

    Varga, A.; Camidge, D. R.; Sequist, L. V.; Wakelee, H.; Ou, S. H.; Goldman, J. W.; Papadimitrakopoulou, V.; Gadgeel, S.; Mekhail, T.; Oxnard, G. R.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • EGFR: The paradigm of an oncogene-driven lung cancer
    Journal Article

    Riely, G. J.; Yu, H. A.
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib
    Journal Article

    Naidoo, J.; Sima, C. S.; Rodriguez, K.; Busby, N.; Nafa, K.; Ladanyi, M.; Riely, G. J.; Kris, M. G.; Arcila, M. E.; Yu, H. A.
    Cancer (2015)

    Fulltext@MSK | Save
  • Phase I dose escalation study of ASP8273, a mutant-selective irreversible EGFR inhibitor, in subjects with EGFR mutation positive NSCLC
    Meeting Abstract

    Yu, H. A.; Oxnard, G. R.; Spira, A. I.; Horn, L.; Weiss, J.; Feng, Y.; West, H. J.; Giaccone, G.; Evans, T. L.; Kelly, R. J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I study of twice weekly pulse dose and daily low dose erlotinib as initial treatment for patients (pts) with EGFR-mutant lung cancers
    Meeting Abstract

    Yu, H. A.; Sima, C. S.; Reales, D.; Jordan, S.; Rudin, C. M.; Kris, M. G.; Michor, F.; Pao, W.; Riely, G. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Efficacy of rociletinib (CO-1686) in plasma-genotyped T790M-positive non-small cell lung cancer (NSCLC) patients (pts)
    Meeting Abstract

    Sequist, L. V.; Goldman, J. W.; Wakelee, H. A.; Camidge, D. R.; Yu, H. A.; Varga, A.; Solomon, B.; Oxnard, G. R.; Ou, S. H. I.; Papadimitrakopoulou, V.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save